News Archive
Endocyte files registration statement with SEC for initial public offering Endocyte announces PRECEDENT interim analysis results Endocyte to present results from four clinical trials at ASCO annual meeting Endocyte announces DSMB supports continuation of phase 2 PRECEDENT study Endocyte presents data on EC145 in treatment of ovarian cancer at the 16th annual meeting of the European Society of Gynaecologic Oncology Endocyte announces close of $26 million equity financing Endocyte announces achievement of second milestone in collaboration with Bristol-Myers Squibb Endocyte announces positive results from a Phase II clinical study of EC145 in patients with advanced non-small cell lung cancer (NSCLC) Endocyte to present data on EC145 at the IASLC 13th World Conference on Lung Cancer Endocyte initiates phase 1 trial of EC0489 for treatment of refractory or metastatic solid tumors Endocyte to present multiple abstracts at the 100th annual meeting of the american association for cancer research (AACR) Endocyte announces positive interim results from phase II clinical trial of EC145 in patients with advanced non-small cell lung cancer (NSCLC) Endocyte begins phase II clinical trial of EC145 for treatment of women with ovarian cancer Endocyte Receives “Indiana Companies to Watch” Award Endocyte Secures $15 Million Venture Debt Facility Endocyte Announces Achievement of Milestone in Collaboration with Bristol-Myers Squibb Endocyte to Present at the 26th Annual JPMorgan Healthcare Conference
–August 30, 2010
–August 17, 2010
–June 05, 2010
–May 11, 2010
–March 03, 2010
–October 27, 2009
–October 21, 2009
–October 15, 2009
–August 26, 2009
–August 10, 2009
–July 14, 2009
–May 05, 2009
–April 17, 2009
–March 24, 2009
–February 19, 2009
–October 13, 2008
–September 10, 2008
–January 25, 2008
–January 04, 2008
–January 03, 2008
Chandra Lovejoy joins Endocyte as Director of Regulatory Affairs Endocyte secures $15 million in Series C-3 round of financing Purdue honors faculty entrepreneurs for life-altering inventions Michael A. Sherman Joins Endocyte as CFO Keith E. Brauer Joins the Endocyte Board of Directors Endocyte Announces Patent Issued to Enhance Cancer Targeting in Immunotherapy Endocyte begins Phase 1 trial of EC145 for treatment of refractory solid tumors Endocyte Signs Agreement with Bristol-Myers Squibb to Develop and Commercialize Folate-Targeted Chemotherapeutic Agents Richard Messmann join’s Endocyte’s executive management team Purdue anchors Indy’s newest technology park, 3 companies move in Emory Researchers Awarded $1.6 Million to Study Common Type of Pituitary Tumor Endocyte’s research to reduce chemo’s side effects receives state-federal dollars WL research ‘triangle’ sprouting walls, jobs Endocyte Inc. named a finalist for an Indiana Ernst & Young Entrepreneur of the Year 2004 Award Purdue Research Park to add 60,000 square feet of incubator space Endocyte Signs Clinical Trials Agreement with the National Cancer Institute for its FolateScan Product August Watanabe, M.D. joins board of directors at Endocyte Endocyte secures $15 million in Series C round of financing Endocyte begins first clinical trial with new metastatic cancer treatment Endocyte Selects eResearch Technology eResearch Network to Deliver Comprehensive Infrastructure New director of clinical operations joins Endocyte team Researchers developing technology to outsmart metastasized cancers Endocyte signs license agreement with Galenica
–December 21, 2007
–December 17, 2007
–March 23, 2007
–November 29, 2006
–October 11, 2006
–October 09, 2006
–September 12, 2006
–May 16, 2006
–April 20, 2006
–January 05, 2006
–November 02, 2005
–July 13, 2005
–April 26, 2005
–March 30, 2005
–December 06, 2004
–November 15, 2004
–August 15, 2004
–May 10, 2004
–April 01, 2004
–November 19, 2003
–October 16, 2003
–September 05, 2003
–August 15, 2003
–May 09, 2003
–May 06, 2003
–January 31, 2003
–October 01, 2002
–June 19, 2002
–May 14, 2002
Endocyte Inc. secures $7.6 million in equity investments Cancer research firm among companies to benefit from grants
–October 01, 2001
–July 10, 2001
–February 22, 2001
